Login
Coverage Universe
Drugs Covered:
3,904
Catalysts Covered:
5,388
Revenue Models:
408
Companies Covered:
934
Companies Evaluated:
27
>>
Advanced Catalyst Search
<<
>>
Advanced Drug Search
<<
>>
Advanced Event Search
<<
Search
Catalysts
Drug Profiles
Impact Events
Company Profiles
Target
Indication
Sample Reports
Special Reports
02/04/10
2010 BioMedTracker Outlook Report
01/19/10
JP Morgan Conference Review
12/21/09
2009 Post-ASH Report
11/30/09
2009 Pre-ASH Report
11/19/09
Vivus (VVUS) Coverage Initiation
11/13/09
H1N1 Influenza Pandemic Tracker
11/02/09
2009 Post-ACR Report
10/15/09
ACR Conference Catalysts
More...
Event Alerts
Date
Lead
Company
Event
Type
Approval
Change
Approval
Likelihood
03/09/10
InterMune (ITMN)
Esbriet for Idiopathic Pulmonary Fibrosis (IPF)
Subscribers Only
Subscribers Only
Subscribers Only
03/09/10
Ark (AKT:LN)
Cerepro for Brain Cancer (malignant glioma; AA and GBM)
Subscribers Only
Subscribers Only
Subscribers Only
03/09/10
Actelion (ATLN:VX)
Zavesca for Niemann-Pick Disease
Subscribers Only
Subscribers Only
Subscribers Only
03/09/10
Biogen IDEC (BIIB)
Daclizumab for Multiple Sclerosis (MS)
Subscribers Only
Subscribers Only
Subscribers Only
03/09/10
Bristol-Myers (BMY)
Onglyza for Diabetes Mellitus, Type II
Subscribers Only
Subscribers Only
Subscribers Only
Expected
Date Range
Lead
Company
Drug
Expected
Catalyst
03/10/10
Subscribers Only
Subscribers Only
Company - Earnings Announcement
03/10/10
Subscribers Only
Subscribers Only
Company - Earnings Announcement
03/10/10
Subscribers Only
Subscribers Only
Company - Earnings Announcement
03/10/10
Subscribers Only
Subscribers Only
Company - Earnings Announcement
03/10/10
Subscribers Only
Subscribers Only
Company - Earnings Announcement
Questions?
Email
Customer Support
Privacy Policy
Important Legal Disclosure
Copyright © 2010 Sagient Research Systems, Inc. All rights reserved.